Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Sanofi to Cut Hundreds of Jobs in Europe

By Drug Discovery Trends Editor | February 3, 2016

​Sanofi alerted labor unions this morning it plans to cut an estimated 600 jobs from its headquarters in France. The drugmaker employs a quarter of its staff — 27,000 people — in Paris.

The reduction is expected to take place over the course of three years, reports Bloomberg. The company did not yet indicate a date when layoffs would begin.

Sanofi union representative Thierry Bodin told the publication the cuts will eliminate 296 research and development positions that were to be filled, along with 155 jobs in the company’s commercial operations department and more than 100 corporate roles that will affect central and support functions.

Olivier Brandicourt, Sanofi’s CEO, is implementing this measure as a way to trim costs and maintain growth through 2020. The drugmaker’s large diabetes business is facing pricing problems and competition from generics for its profitable Lantus insulin, which is the third best-selling medicine in this category.

Sanofi said layoffs will also take place outside of France. The company has more than 110,000 employees in 100 countries, according to its website. Sanofi may announce more details during its earnings call on February 9. 


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50